NIH-funded research NIH-funded research

A new imaging system for studying cancer in small animals

Official title: The Super Argus PET/CT 6R for Pre-clinical Oncology Research

Funded at Sloan-Kettering Inst Can Research · NIH-10852626 · Data updated 2026-11-12

This study is all about getting a new, advanced scanner to help scientists at Memorial Sloan Kettering Cancer Center better understand how cancer grows and responds to treatments in mice and rats, which could lead to better therapies for people with cancer.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionSloan-Kettering Inst Can Research
NIH-funded
Lab location1 site (New York, United States)
Project startSeptember 1, 2024
Project endAugust 14, 2025
Funding year2024
Award (this year)$1,391,522
NIH project number1S10OD036298-01
Project IDNIH-10852626 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for participation or benefit from this research are individuals with cancer or those interested in the biological mechanisms of cancer treatment.

Less likely to help

Patients who are not involved in pre-clinical research or do not have a cancer diagnosis may not receive direct benefits from this research.

What this research studies

This research focuses on acquiring a state-of-the-art Super Argus PET/CT 6R scanner to enhance pre-clinical oncology research. The scanner will be used to monitor cancer progression and treatment responses in mouse and rat models, allowing researchers to non-invasively assess the effectiveness of new cancer therapies. By evaluating how cancer and immune cells behave and respond to treatments, this research aims to improve our understanding of cancer biology and therapeutic interventions. The facility will serve as a vital resource for ongoing cancer research at Memorial Sloan Kettering Cancer Center.

Why it matters

Potential benefit: If successful, this research could lead to more effective cancer treatments by providing insights into how therapies work at the cellular level.

How similar studies have gone: Other research has successfully utilized advanced imaging technologies in pre-clinical oncology, indicating a strong potential for this approach.

Where this research is happening

  • Sloan-Kettering Inst Can Research
    New York, United States
    Active

Researchers

  • Principal investigator: Zanzonico, Pat B — Sloan-Kettering Inst Can Research
  • Study coordinator: Zanzonico, Pat B

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.